Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enphase Energy | ENPH | Jan 14, 2025 | 65.45 | -2.12 |
Enpro | NPO | Jan 14, 2025 | 166.69 | +1.93 |
Enservco | ENSV | Jan 14, 2025 | 0.03 | -3.13 |
Enstar Group | ESGR | Jan 14, 2025 | 326.50 | +0.13 |
Enstar Group Depository E Pref | ESGRO | Jan 14, 2025 | 20.23 | -0.61 |
Enstar Pref | ESGRP | Jan 14, 2025 | 20.11 | +0.50 |
Ensysce Biosciences | ENSC | Jan 14, 2025 | 6.75 | -5.86 |
Entegris | ENTG | Jan 14, 2025 | 99.50 | +1.26 |
Entera Bio | ENTX | Jan 14, 2025 | 2.36 | -1.67 |
Entergy | ETR | Jan 14, 2025 | 77.56 | +0.64 |
Entergy Texas A Pref | ETI- | Jan 14, 2025 | 23.34 | +0.60 |
Entergy Utility Enterprises | EMP | Jan 14, 2025 | 21.18 | +0.88 |
Entero Therapeutics | ENTO | Jan 14, 2025 | 0.56 | +3.45 |
Enterprise Bancorp | EBTC | Jan 14, 2025 | 39.19 | +3.87 |
Enterprise Financial Services | EFSC | Jan 14, 2025 | 56.57 | +3.61 |
Enterprise Financial Services A Pref | EFSCP | Jan 14, 2025 | 18.90 | +0.39 |
Enterprise Products Partners LP Unit | EPD | Jan 14, 2025 | 33.45 | +2.80 |
Entrada Therapeutics | TRDA | Jan 14, 2025 | 12.49 | -6.58 |
Entravision Communications | EVC | Jan 14, 2025 | 2.41 | +0.42 |
Envela | ELA | Jan 14, 2025 | 6.76 | -2.73 |
Enveric Biosciences | ENVB | Jan 14, 2025 | 0.37 | -2.19 |
Enviri | NVRI | Jan 14, 2025 | 8.60 | +2.38 |
Environmental Svcs ETF Market Vectors | EVX | Jan 14, 2025 | 174.32 | +0.22 |
Envirotech Vehicles | EVTV | Jan 14, 2025 | 1.14 | 0.00 |
Envista | NVST | Jan 14, 2025 | 18.85 | -0.74 |
Envoy Medical A | COCH | Jan 14, 2025 | 1.40 | -11.55 |
enVVeno Medical | NVNO | Jan 14, 2025 | 3.14 | -1.57 |
Enzo Biochem | ENZ | Jan 14, 2025 | 0.65 | -2.15 |
EOG Resources | EOG | Jan 14, 2025 | 135.77 | +0.95 |
EON Resources A | EONR | Jan 14, 2025 | 1.02 | -9.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.